u/MaxInPhilly

27 post karma · 15 comment karma · joined May 2026

  1. 13points

    The market is pricing this company for bankruptcy. The reality is a clinical monopoly and looming commercial turnaround (self.TheRaceTo10Million) [Due Diligence]

    17 comments

  2. 13points

    The market is pricing this company for bankruptcy. The reality is a clinical monopoly and looming commercial turnaround

    6 comments · source

  3. 0points

    The market is pricing this company for bankruptcy. The reality is a clinical monopoly and looming commercial turnaround

    1 comments · source

  4. 0points

    DRTS to CHRS: Why I’m thinking about switching gains into CHRS (self.DRTS_Stock)

    30 comments

  5. 16points

    The $1.44 Oncology stock with a $8–$12 Price Targets $CHRS my DD post (self.TenBaggerStockPicks)

    25 comments